Target Name: SEMA6D
NCBI ID: G80031
Review Report on SEMA6D Target / Biomarker Content of Review Report on SEMA6D Target / Biomarker
SEMA6D
Other Name(s): KIAA1479 | SEMA6D variant 7 | Semaphorin 6D, transcript variant 4 | Semaphorin 6D | Semaphorin 6D, transcript variant 1 | Semaphorin 6D, transcript variant 9 | Semaphorin-6D isoform 7 precursor (isoform 7) | semaphorin 6D | FLJ11598 | Semaphorin 6D, transcript variant 7 | Semaphorin-6D | Semaphorin-6D (isoform 1) | Semaphorin-6D (isoform 4) | SEMA6D variant 4 | SEMA6D variant 1 | SEMA6D variant 9 | Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D | SEM6D_HUMAN

SEMA6D: Potential Therapeutic Targets

SEMA6D (KiAA1479) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and heart. Its function is not well understood, but research has suggested that it may be involved in a number of different processes, including cell signaling, inflammation, and stress response.

One of the key features of SEMA6D is its role in the kilometer-long non-coding RNA (miRNA) pathway. This pathway is a well-established mechanism for regulating gene expression by silencing the expression of target genes. SEMA6D has been shown to play a role in the regulation of miRNA expression by binding to a protein called PIK3CA, which is a key regulator of the miRNA pathway.

SEMA6D has also been shown to be involved in the regulation of cellular stress responses. When cells are exposed to stress, they produce a variety of signaling molecules to help them cope with the stressor. SEMA6D has also been shown to be involved in the regulation of these signaling pathways by binding to a protein called CREB-Claudin 2 (CREB-Claudin 2), which is a protein that is involved in the transcriptional response to stress.

In addition to its role in stress response, SEMA6D has also been shown to be involved in the regulation of cell proliferation. When cells are growing, they need to maintain accurate copies of their genetic material, and SEMA6D has been shown to be involved in the regulation of the copy number of a gene called PMEL1.

SEMA6D has also been shown to be involved in the regulation of differentiation. When cells differentiate into specific types of cells, they need to maintain the accuracy of their gene expression profiles. SEMA6D has also been shown to be involved in the regulation of the expression of a gene calledDLK1, which is involved in the process of cell differentiation.

In conclusion, SEMA6D is a protein that has been shown to be involved in a number of different processes in the body. While more research is needed to fully understand its function, its potential as a drug target or biomarker is significant. Further studies are needed to determine the exact mechanisms by which SEMA6D is involved in these processes and to explore its potential as a therapeutic agent.

Protein Name: Semaphorin 6D

Functions: Shows growth cone collapsing activity on dorsal root ganglion (DRG) neurons in vitro. May be a stop signal for the DRG neurons in their target areas, and possibly also for other neurons. May also be involved in the maintenance and remodeling of neuronal connections

The "SEMA6D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEMA6D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SEMA7A | Semenogelin | SEMG1 | SEMG2 | SENCR | SENP1 | SENP2 | SENP3 | SENP3-associated complex | SENP3-EIF4A1 | SENP5 | SENP6 | SENP7 | SENP8 | SEPHS1 | SEPHS1P4 | SEPHS1P6 | SEPHS2 | SEPSECS | SEPSECS-AS1 | SEPT5-GP1BB | SEPTIN1 | SEPTIN10 | SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2